论文部分内容阅读
目的观察青金抗毒饮治疗病毒性心肌炎的临床疗效。方法将80例病毒性心肌炎患者随机分为治疗组与对照组各40例,对照组给予西医常规治疗;治疗组在常规西医治疗的基础上,口服青金抗毒饮,两组均以4周为1个疗程。于治疗前后进行心功能(心率、心输出量、心搏量、射血分数、心脏指数)及心肌酶谱(乳酸脱氢酶、肌酸激酶、肌酸激酶同工酶)检测,并观察临床疗效及心电图疗效。结果治疗组临床疗效总有效率为92.50%,对照组总有效率为80.00%,治疗组临床疗效优于对照组(P<0.05)。治疗组心电图疗效总有效率为92.50%,对照组总有效率为85.00%,治疗组心电图疗效优于对照组(P<0.05)。两组治疗后心功能及心肌酶谱各项指标较治疗前均明显好转,差异有统计学意义(P<0.05),且治疗后治疗组各指标优于对照组(P<0.05)。结论青金抗毒饮治疗病毒性心肌炎临床疗效肯定,能改善患者心功能及心肌酶谱。
Objective To observe the clinical efficacy of Qingjin anti-drug drink in the treatment of viral myocarditis. Methods Eighty patients with viral myocarditis were randomly divided into treatment group (40 cases) and control group (40 cases). The control group was given routine western medicine treatment. On the basis of routine Western medical treatment, the treatment group was given Qingjin anti-poison drink. Both groups were treated with 4 weeks For a course of treatment. Cardiac function (heart rate, cardiac output, stroke volume, ejection fraction, cardiac index) and myocardial enzymes (lactate dehydrogenase, creatine kinase, creatine kinase isoenzyme) were measured before and after treatment. Efficacy and ECG efficacy. Results The total effective rate was 92.50% in the treatment group and 80.00% in the control group. The clinical efficacy of the treatment group was better than that of the control group (P <0.05). In the treatment group, the total effective rate of electrocardiogram was 92.50% and that of the control group was 85.00%. The electrocardiogram of the treatment group was better than that of the control group (P <0.05). The indexes of cardiac function and myocardial enzymes in both groups were significantly improved after treatment compared with those before treatment (P <0.05), and the indexes in the treatment group were better than those in the control group after treatment (P <0.05). Conclusion Qingjin anti-drug drink treatment of viral myocarditis positive effect, can improve cardiac function and myocardial enzymes.